- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on B Cell Lymphomas in Hong Kong
Total 852 results
-
GlaxoSmithKlineCompletedHepatitis BSingapore, China, Hong Kong, Japan, Korea, Republic of, Philippines
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedLung CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
National Cancer Institute (NCI)RecruitingPrimary Mediastinal Large B-Cell LymphomaUnited States, Canada, Australia, Puerto Rico
-
NovartisTerminatedHepatitis BKorea, Republic of, Thailand, United States, Hong Kong, Taiwan
-
National Cancer Centre, SingaporeSingapore General HospitalRecruitingNon-Small Cell Lung Cancer | Lung CancerThailand, Singapore, Hong Kong, Brunei Darussalam, India, Malaysia
-
Assembly BiosciencesTerminatedChronic Hepatitis BHong Kong, United States, New Zealand
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Korea, Republic of, Taiwan, Thailand
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Vir Biotechnology, Inc.CompletedChronic Hepatitis BGermany, Hong Kong, Korea, Republic of, New Zealand, Romania, Singapore, United Kingdom
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
Assembly BiosciencesCompletedChronic Hepatitis BUnited States, Canada, Hong Kong, New Zealand, United Kingdom
-
Vir Biotechnology, Inc.Active, not recruitingHepatitis B, ChronicHong Kong, Korea, Republic of, United Kingdom, France, Moldova, Republic of, Romania
-
NovartisNovartis PharmaceuticalsCompletedChronic Hepatitis BAustralia, Canada, France, United States, Taiwan, Korea, Republic of, Singapore, Thailand, China
-
Hoffmann-La RocheCompletedChronic Hepatitis BAustralia, Hong Kong, Korea, Republic of, Taiwan, Thailand, New Zealand, Singapore
-
Gilead SciencesVir Biotechnology, Inc.Active, not recruitingChronic Hepatitis BHong Kong, Korea, Republic of, Denmark, Australia, Thailand, Singapore, United Kingdom, New Zealand
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerTaiwan, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Brii Biosciences LimitedVir Biotechnology, Inc.Active, not recruitingChronic Hepatitis B Virus InfectionSingapore, Thailand, Australia, China, Korea, Republic of
-
Assembly BiosciencesCompletedChronic Hepatitis BKorea, Republic of, Australia, United States, Hong Kong, United Kingdom, China, New Zealand
-
Hoffmann-La RocheRecruitingChronic Hepatitis BKorea, Republic of, United States, Thailand, Hong Kong, Spain, New Zealand, Bulgaria, Taiwan, France
-
AlexionAchillion, a wholly owned subsidiary of AlexionTerminatedChronic Hepatitis BUnited States, Canada, China
-
MEI Pharma, Inc.Kyowa Kirin, Inc.TerminatedPhase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)United States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Taiwan, Australia, Poland, Italy, Canada, Georgia, Greece, Hungary, Netherlands, New Zealand, Serbia, Turkey
-
Vir Biotechnology, Inc.Alnylam PharmaceuticalsActive, not recruitingChronic Hepatitis BAustralia, Hong Kong, Korea, Republic of, Malaysia, New Zealand, Thailand
-
Immunocore LtdRecruitingHepatitis B, ChronicHong Kong, Korea, Republic of, Taiwan, Denmark, United States, Australia, Romania, United Kingdom, Spain
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
Bukwang PharmaceuticalTerminatedHepatitis BKorea, Republic of
-
PfizerTerminatedAdvanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)United States, Spain, Hong Kong, Belgium, Australia, France
-
Bukwang PharmaceuticalTerminatedHepatitis BKorea, Republic of
-
Merck Sharp & Dohme LLCRecruitingLeukemia, Lymphocytic, Chronic, B-Cell | Lymphoma, Small Lymphocytic | CLL | SLL | Small-Cell Lymphoma | Leukemia, Chronic LymphocyticItaly, Argentina, Chile, Brazil, Israel, South Africa, United States, Australia, Puerto Rico, Spain, Canada, Germany, France, United Kingdom, Colombia
-
AbbVieCompletedChronic Lymphocytic Leukemia (CLL)Argentina, Australia, Bulgaria, Hong Kong, Hungary, Mexico, New Zealand, Poland, Russian Federation, Taiwan
-
Novartis PharmaceuticalsCompletedMelanoma | CancerTaiwan, Thailand, China, Hong Kong, Korea, Republic of
-
Hoffmann-La RocheCompletedHepatitis B, ChronicThailand, Taiwan, United Kingdom, Hong Kong, Netherlands, New Zealand, Bulgaria, Italy
-
Novartis PharmaceuticalsTerminatedColorectal Cancer | Gastrointestinal Stromal Tumors | Non-small Cell Lung Carcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal SCCUnited States, Germany, Spain, Singapore, Australia, Hong Kong, Belgium, Japan, China
-
Bukwang PharmaceuticalCompletedHepatitis BKorea, Republic of
-
Arbutus Biopharma CorporationActive, not recruitingChronic Hepatitis bUnited States, Korea, Republic of, Hong Kong, Taiwan, Australia, Moldova, Republic of, Ukraine
-
TJ Biopharma Co., Ltd.Active, not recruitingNewly Diagnosed GlioblastomaChina, Hong Kong
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerHong Kong, Taiwan, Philippines, China, Thailand, Indonesia, Australia, Korea, Republic of
-
Bukwang PharmaceuticalCompletedHepatitis BKorea, Republic of
-
Bukwang PharmaceuticalTerminatedHepatitis BKorea, Republic of
-
Dong-A UniversityCompletedMicroinvasive Squamous Cell CarcinomaKorea, Republic of
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage I Childhood Hodgkin Lymphoma | Ann Arbor Stage II Childhood Hodgkin Lymphoma | Childhood Nodular Lymphocyte Predominant B-Cell LymphomaUnited States, Canada, Australia, New Zealand, Puerto Rico, Israel
-
Bukwang PharmaceuticalTerminatedHepatitis BKorea, Republic of
-
Hoffmann-La RocheCompletedHepatitis B, ChronicAustralia, New Zealand, Singapore, Thailand, Taiwan, China, Bulgaria, Hong Kong
-
Assembly BiosciencesTerminatedChronic Hepatitis BUnited States, Canada, Hong Kong, New Zealand, United Kingdom
-
AbbVieAvailableNon-Small Cell Lung Cancer (NSCLC)Australia, Hong Kong, Israel, United States, Germany
-
Bukwang PharmaceuticalTerminatedHepatitis BKorea, Republic of
-
AbbVieActive, not recruitingAcute Myeloid Leukemia | Cancer | Multiple Myeloma | Non-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic LeukemiaUnited States, Australia, Belgium, Canada, Denmark, France, Greece, Hong Kong, Ireland, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Portugal, Russian Federation, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Au...
-
Novartis PharmaceuticalsActive, not recruitingALK-positive NSCLCBelgium, Spain, Italy, Australia, United States, Hong Kong, Canada, Singapore
-
Bukwang PharmaceuticalTerminatedHepatitis BKorea, Republic of
-
Sun Yat-sen UniversityUnknownHepatitis B, ChronicChina